{[ promptMessage ]}

Bookmark it

{[ promptMessage ]}

Eng 2000 Article - Gene Therapy - Approval

Eng 2000 Article - Gene Therapy - Approval -...

Info iconThis preview shows page 1. Sign up to view the full content.

View Full Document Right Arrow Icon
http://www4.od.nih.gov/oba/rac/cover.htm Oversight of government-funded experiments involving gene therapy for human patients occurs at both the local and national levels. At the local level, facilities at which experiments would take place are required to have two types of committees. First, hospitals and universities involved in experiments with human subjects are required to have Institutional Review Boards (IRB) to ensure that the research complies with Department of Health and Human Services (DHHS) regulations for protection of human subjects. Second, experiments that involve gene insertion must be approved in advance by an Institutional Biosafety Committee (IBC). These local review boards provide an opportunity for the general public to become involved in the decisions made about research involving gene therapy for human patients. The DHHS regulations require that at least one nonscientist serve as a member of each IRB. Further, the NIH Guidelines for Research Involving Recombinant DNA Molecules
Background image of page 1
This is the end of the preview. Sign up to access the rest of the document.

{[ snackBarMessage ]}

Ask a homework question - tutors are online